Mizu Sakai
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Correction: Venetoclax treatment for chronic lymphocytic leukemia/small lymphocytic leukemia in Japan: post-marketing surveillance.
Journal: International journal of hematology
Published: April 11, 2025
Venetoclax treatment for chronic lymphocytic leukemia/small lymphocytic leukemia in Japan: post-marketing surveillance.
Journal: International journal of hematology
Published: January 26, 2024
A Phase I Trial of Weekly Nab-paclitaxel Plus Carboplatin With Thoracic Radiotherapy for Non-small Cell Lung Cancer.
Journal: In vivo (Athens, Greece)
Published: August 28, 2023
Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax.
Journal: International journal of hematology
Published: March 24, 2023
Primary adrenal Ewing's sarcoma family of tumors with tumor thrombus of the inferior vena cava: a case report.
Journal: Journal of medical case reports
Published: November 13, 2022
Carboplatin plus Weekly Paclitaxel with Bevacizumab for First-line Treatment of Non-small Cell Lung Cancer.
Journal: Anticancer research
Published: January 02, 2016
Young adult onset systemic Epstein-Barr virus-positive T-cell lymphoproliferative disorders of childhood.
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: June 12, 2015
Successful re-administration of lenalidomide after lenalidomide-induced pulmonary alveolar hemorrhage in a patient with refractory myeloma.
Journal: Annals of hematology
Published: October 22, 2014
Effect of recombinant human soluble thrombomodulin on clinical outcomes of patients with coagulopathy after hematopoietic stem cell transplantation.
Journal: European journal of haematology
Published: August 11, 2013
A novel lung injury animal model using KL-6-measurable human MUC1-expressing mice.
Journal: Biochemical and biophysical research communications
Published: January 06, 2013
Recombinant human soluble thrombomodulin safely and effectively rescues acute promyelocytic leukemia patients from disseminated intravascular coagulation.
Journal: Leukemia research
Published: May 30, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026